WallStSmart
BTSG

BrightSpring Health Services, Inc. Common Stock

NASDAQ: BTSG · HEALTHCARE · HEALTH INFORMATION SERVICES

$54.83
+0.00% today

Updated 2026-06-05

Market cap
$11.97B
P/E ratio
79.22
P/S ratio
0.88x
EPS (TTM)
$0.77
Dividend yield
52W range
$19 – $62
Volume
2.7M

BrightSpring Health Services, Inc. Common Stock (BTSG) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for BTSG.

WallStSmart Verdict
Fairly
Valued

Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.

Smart Value Score: 53 / 100
P/E (TTM)
79.2x
vs 5Y median of 95.2x
PEG
Margin of Safety
DCF limited for this profile
EV / EBITDA
26.1x

BTSG historical valuation range

Where current P/E sits in BTSG's own 5Y range.

NOW
61.4x
5Y Low
78.4x
25th
95.2x
Median
100.2x
75th
109.5x
5Y High
BTSG is trading cheaper than 67% of the last 5Y.
33th percentile · Below median

BTSG intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

DCF has limited applicability for BTSG

Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

BTSG valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

!
P/E in mid-range
P/E sits at the 33th percentile of the 5Y range. Neither cheap nor rich historically.
!
DCF limited applicability
Company profile produces unstable DCF output. Lean on P/S, EV/Sales, and historical valuation position instead of intrinsic value for this stock.

P/E Ratio — History

Current: 79.22x

P/S Ratio — History

Current: 0.88x

Is BTSG overvalued in 2026?

BrightSpring Health Services, Inc. Common Stock (BTSG) currently trades at $54.83 per share with a market capitalization of $11,971,763,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 53/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

The stock trades at a P/E ratio of 79.2x, below its 5-year median of 95.2x.

Looking at its own history, BTSG is currently trading cheaper than 67% of the last 5Y on P/E. This places it in the 33th percentile of its historical range, a reasonable but unremarkable position.

A standard DCF model does not produce reliable output for BTSG under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.

The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.

Bottom line: BTSG trades at a fair valuation on our framework, with a Smart Value Score of 53/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.

Frequently asked questions

Is BTSG overvalued?

BTSG scores 53/100 on our Smart Value Score (Grade C), a mixed overall profile. A standard DCF is unreliable here given the profitability profile, so valuation leans on revenue-based measures like EV/Sales and the P/S percentile below.

What is BTSG's fair value?

A standard DCF is unreliable for BTSG given its current profitability profile. Revenue-based approaches like EV/Sales or the historical P/S percentile are more informative for this stock.

What P/E ratio does BTSG trade at?

BTSG trades at a P/E of 79.2x on trailing twelve-month earnings, against a 5-year median of 95.2x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.

Is BTSG a buy based on valuation?

Our Smart Value rating for BTSG is Hold, from a Smart Value Score of 53/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.

How does BTSG's valuation compare to its history?

On P/E, BTSG sits in the 33rd percentile of its own 5Y range, below its long-run median relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.

What is BTSG's Smart Value Score?

BTSG's Smart Value Score is 53/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.